1. Home
  2. NEPH vs GROW Comparison

NEPH vs GROW Comparison

Compare NEPH & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$2.88

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Logo U.S. Global Investors Inc.

GROW

U.S. Global Investors Inc.

HOLD

Current Price

$3.11

Market Cap

31.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEPH
GROW
Founded
1997
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
31.0M
31.3M
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
NEPH
GROW
Price
$2.88
$3.11
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
46.3K
15.8K
Earning Date
03-12-2026
05-07-2026
Dividend Yield
N/A
2.92%
EPS Growth
1000.00
N/A
EPS
0.11
0.05
Revenue
$18,789,000.00
$23,850,609.00
Revenue This Year
$12.82
N/A
Revenue Next Year
$10.02
N/A
P/E Ratio
$26.91
$61.80
Revenue Growth
32.67
N/A
52 Week Low
$1.51
$2.05
52 Week High
$6.42
$3.65

Technical Indicators

Market Signals
Indicator
NEPH
GROW
Relative Strength Index (RSI) 29.42 44.96
Support Level N/A $3.10
Resistance Level $4.93 $3.43
Average True Range (ATR) 0.24 0.11
MACD -0.09 -0.04
Stochastic Oscillator 5.24 47.17

Price Performance

Historical Comparison
NEPH
GROW

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

Share on Social Networks: